Brief news reports on Tuberculosis

WHO/EU “bad medicine” plans: flaws, coordination gaps

The latest World Health Organization / European Union plans to counter the trade in counterfeit and substandard medicines aim to ensure that medicines in the developing world are safe. As such, though both plans appropriately address quality issues, they fall short of adequate coordination and collaboration with each other, and also present substantial flaws.

Read More →

New initiative launched to deliver better, cheaper medicines to Africa

The need to ensure that people in Africa have access to essential, high quality, safe  and affordable medicines has just received a major boost with the launch of the East African Community (EAC) Medicines Registration Harmonization Project in Arusha, Tanzania, on 30 March 2011. 

Read More →

Trials done for shorter TB treatment

South African researchers said on Friday they were conducting medical trials to shorten the duration of tuberculosis treatment, to make it easier for patients to complete the full regimen.

Read More →

Stop TB Partnership Working Group on New Drugs launches Innovate TB contest

30 March 2012 - The Working Group on New Drugs invites people around the world to submit videos, photos or written accounts of new approaches that can help to achieve zero deaths from TB in this generation.

Read More →

Limited provision of TB services in prison in countries receiving Global Fund grants

Only 50% of countries in receipt of grants from the Global Fund to Fight AIDS, Tuberculosis and Malaria provide tuberculosis (TB) services in prisons, according to research published in a special supplement of the Journal of Infectious Diseases.

Read More →

An unfortunate judgment

Supreme Court of Appeal overturns Cape High Court's TB in prisons ruling.

Read More →

Losing Ground: How funding shortfalls and the cancellation of the Global Fund’s Round 11 are jeopardising the fight against HIV & TB

"Losing Ground" describes the impact of funding shortfalls in critical areas of HIV and TB in 13 countries where MSF work.

Read More →

2 drugs already on the market show promise against tuberculosis

SAN DIEGO, March 26, 2012 — A two-drug combination is one of the most promising advances in decades for the treatment of tuberculosis (TB) — a disease that kills 2 million people annually — a scientist reported today at the 243 National Meeting & Exposition of the American Chemical Society (ACS). The treatment, which combines two medications already approved by the U.S. Food and Drug Administration (FDA), delivers a knockout punch to forms of TB that shrug off other antibiotics.

Read More →

Russia: Several regional hospitals face stock-outs of TB medicines

Representatives of Russian NGOs say that several regional hospitals face stock-outs of TB medicines, which in turn may lead to a mortality increase among TB-infected patients. This situation, according to them, is closely linked to the refusal of the Ministry of Health and Social Development of the Russian Federation (MSHD) to accept aid from the Global Fund to Fight AIDS, Tuberculosis and Malaria. The Fund was ready to donate $127 mln to the Russian Federation, but in response Russia itself expressed its willingness to become a donor of the Global Fund.

Read More →

NICE: New guidance points the way to tackling tuberculosis among hard-to-reach groups

New public health guidance from NICE published today, ahead of World TB day (24 March), provides a blueprint for improving the way tuberculosis (TB) is identified and managed among groups of people who are hard to reach through traditional health care services.

Read More →

Page 530 of 580 · Total posts: 10

←First 529 530 531 Last→